🇺🇸 Coenzyme Q in United States

361 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 46 reports (12.74%)
  2. Diarrhoea — 41 reports (11.36%)
  3. Asthenia — 39 reports (10.8%)
  4. Nausea — 39 reports (10.8%)
  5. Headache — 38 reports (10.53%)
  6. Dizziness — 35 reports (9.7%)
  7. Dyspnoea — 33 reports (9.14%)
  8. Urinary Tract Infection — 31 reports (8.59%)
  9. Eye Pain — 30 reports (8.31%)
  10. Fall — 29 reports (8.03%)

Source database →

Coenzyme Q in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Coenzyme Q approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Coenzyme Q in United States?

Sherief Abd-Elsalam is the originator. The local marketing authorisation holder may differ — check the official source linked above.